The World's first-ever personalised mRNA cancer vaccination for melanoma, skin cancer, is being tested in UK patients.
As per Sky News, the ‘game changer’ vaccination has the potential to stop three more: lung, bladder and kidney cancer.
The vaccination is custom built for everyone and directs the body to identify the cancer cells and prevent the return of the disease.
Moreover, in the second phase, it was found that the jab is significant for reducing the risk of cancer return in melanoma patients.
The University College London Hospitals NHS Foundation Trust (UCLH) is leading the final trial.
Dr Heather Shaw, who is coordinating the investigative trials, expressed that it was “One of the most exciting things we've seen in a really long time. This is a really finely honed tool.”
She furthered, “To be able to sit there and say to your patients that you're offering them something that's effectively like the Fat Duck at Bray versus McDonald's - it's that level of cordon bleu that's coming to them.”
Shaw mentioned, “These things are hugely technical and finely generated for the patient. The patients are really excited about them.”
Moreover, Dr Shaw explained, “This is very much an individualised therapy, and it's far cleverer in some senses than a vaccine. It is absolutely custom-built for the patient; you couldn't give this to the next patient in the line because you wouldn't expect it to work.”
